Hone your critical thinking skills on Lipids, Cardiovascular Health, Nutrition and Obesity by registering for our live case review with Michael Via, MD, ECNU.

Join the webinar for an interactive discussion about the answer to this and several other cases:

A 48-year-old woman who has been receiving treatment for obesity is having a follow-up visit 9 months after starting subcutaneous semaglutide 2.4 mg weekly in addition to lifestyle modification. Her body mass index (BMI) at the start of the therapy was 34 kg/m2, she had mild hypertension treated with hydrochlorothiazide, and you counseled her about the cardiometabolic benefits of losing 10% or more of her weight at that time. Since then, she has introduced recommended changes to her diet, slightly increased physical activity, tolerated semaglutide well, and lost 11% of her weight; her current BMI is 30 kg/m2. Her blood pressure has been normal in the last 3 months without hydrochlorothiazide. She is happy with her progress and wishes to stop semaglutide 2.4 mg weekly now. What would be the best approach to therapy and counseling at this time?

Learn the best approach to therapy and counseling for this case and more on April 20 at 7:00 PM EST.

Register now

Did you miss our previous sessions? You can still register and view the sessions you missed on-demand, along with all of the other useful ASAP tools.

Endocrine Practice is our official peer-reviewed journal containing original articles, review articles, commentaries, editorials, our latest clinical practice guidelines, consensus statements, position statements and more.

Access to Endocrine Practice is an AACE community member benefit. If you're not already part of our community, join us now to gain full access.

Here are some highlights from this issue:

• Risk Assessment and Coronary Artery Calcium Scoring in Transgender and Gender-Diverse Individuals Receiving Gender-Affirming Hormone Therapy

• A Parathyroid Hormone–Guided Calcium and Calcitriol Supplementation Protocol Reduces Hypocalcemia-Related Readmissions Following Total Thyroidectomy

• Transition Readiness in Adolescents and Young Adults Living With Congenital Adrenal Hyperplasia



• Clinical Presentation and Diagnostic Approach to Hypoglycemia in Adults Without Diabetes Mellitus

Read the full issue

Listen to AACE Podcast episode 36, as endocrine expert Vin Tangpricha, MD, PhD, interviews internationally known clinician, epidemiologist, and Interim Dean of Emory University School of Medicine, Carlos del Rio, MD, about the importance of vaccines, how vaccines are made, developed, and approved, and how to use this information to address patients’ questions or hesitancy towards vaccines.

Listen now

Join us in our initiative with the Centers for Disease Control and Prevention (CDC) and the Council for Medical Specialty Societies (CMSS) to advance immunizations. Visit our immunization web page and browse helpful resources, like our downloadable pocket guide.

Don't miss our AACE Advancing Immunization booth at AACE 2023 in Seattle! Details coming soon.

Visit our immunization web page

April 20 — ASAP live webinar: Lipids, CV Health, Nutrition & Obesity

May 4-6 — AACE 2023 Annual Meeting at the Seattle Convention Center – Summit Building in Seattle, WA

May 15 — Review and Dispute Deadline for CMS Open Payments

June 22 — ASAP live webinar: Bone & Parathyroid Disorders

Aug. 17 — ASAP live webinar: Reproductive Disorders

Sept. 21 — ASAP live webinar: Thyroid Disorders

Oct. 12 — ASAP live webinar: Diabetes 2

Nov. 16-18 — Endocrine University Year 2

Nov. 17-19 — AACE MENA at the Grand Hyatt Dubai, United Arab Emirates